Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
Shen P, Yang J, Wei W, Li Y, Li D, Zeng H, Wang J.
BJU Int. 2012 Jan 31. doi: 10.1111/j.1464-410X.2011.10892.x. [Epub ahead of print]
Related citations
Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
Koga F, Fujii Y, Masuda H, Numao N, Yokoyama M, Ishioka JI, Saito K, Kawakami S, Kihara K.
BJU Int. 2012 Jan 30. doi: 10.1111/j.1464-410X.2011.10874.x. [Epub ahead of print]
Current status of molecular markers for prognostication and outcome in invasive bladder cancer.
Gakis G, Schwentner C, Todenhoefer T, Stenzl A.
BJU Int. 2012 Jan 11. doi: 10.1111/j.1464-410X.2011.10839.x. [Epub ahead of print]
Robot-assisted nerve-sparing radical cystectomy with bilateral extended pelvic lymph node dissection (PLND) and intracorporeal urinary diversion for bladder cancer: initial experience in 27 cases.
Canda AE, Atmaca AF, Altinova S, Akbulut Z, Balbay MD.
BJU Int. 2011 Dec 16. doi: 10.1111/j.1464-410X.2011.10794.x. [Epub ahead of print]
Probiotics, dendritic cells and bladder cancer.
Feyisetan O, Tracey C, Hellawell GO.
BJU Int. 2012 Jun;109(11):1594-7. doi: 10.1111/j.1464-410X.2011.10749.x. Epub 2011 Dec 16.
Oncological outcomes of robot-assisted radical cystectomy.
Choudhury SM, Mahesan NM, Elhage O, Khan MS, Dasgupta P.
BJU Int. 2011 Dec;108(11):1679-80. doi: 10.1111/j.1464-410X.2011.10646.x. Epub 2011 Nov 1. No abstract available.
From Leonardo to da Vinci: the history of robot-assisted surgery in urology.
Yates DR, Vaessen C, Roupret M.
BJU Int. 2011 Dec;108(11):1708-13; discussion 1714. doi: 10.1111/j.1464-410X.2011.10576.x. Epub 2011 Sep 27.
The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard.
Isfoss BL.
BJU Int. 2011 Dec;108(11):1703-7. doi: 10.1111/j.1464-410X.2011.10485.x. Epub 2011 Jul 20. Review.
Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
Gakis G, Todenhöfer T, Renninger M, Schilling D, Sievert KD, Schwentner C, Stenzl A.
BJU Int. 2011 Dec;108(11):1800-5. doi: 10.1111/j.1464-410X.2011.10234.x. Epub 2011 Apr 20.
The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy.
Lee R, Ng CK, Shariat SF, Borkina A, Guimento R, Brumit KF, Scherr DS.
BJU Int. 2011 Dec;108(11):1886-92. doi: 10.1111/j.1464-410X.2011.10114.x. Epub 2011 Apr 18.
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG, Nazir SA, Mallett S, Turney BW, Onwu NN, Roberts IS, Crew JP, Cowan NC.
BJU Int. 2011 Nov 28. doi: 10.1111/j.1464-410X.2011.10664.x. [Epub ahead of print]
Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
Choudhury A, Cowan R.
BJU Int. 2011 Nov;108(9):E313. doi: 10.1111/j.1464-410X.2011.10672_3.x. No abstract available.
Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P, Finney SM, Head E, Somani BK, Zachou A, Smith G, Mishriki SF, N'dow J, Grigor KM; for members of the Edinburgh Urological Cancer Group.
BJU Int. 2012 Jun;109(11):1666-73. doi: 10.1111/j.1464-410X.2011.10571.x. Epub 2011 Nov 1.
Future prospects for bladder cancer biomarkers.
Mukhtar S, Perry MJ.
BJU Int. 2011 Nov;108(10):1541-3. doi: 10.1111/j.1464-410X.2011.10642.x. No abstract available.
'One stop' haematuria clinic in Fremantle Hospital, Western Australia: a report of the first 500 patients.
Ooi WL, Lee F, Wallace DM, Hayne D.
BJU Int. 2011 Nov;108 Suppl 2:62-6. doi: 10.1111/j.1464-410X.2011.10711.x.
Male flexible cystoscopy: does waiting after insertion of topical anaesthetic lubricant improve patient comfort?
Losco G, Antoniou S, Mark S.
BJU Int. 2011 Nov;108 Suppl 2:42-4. doi: 10.1111/j.1464-410X.2011.10696.x.
A one-port pneumovesicum method in en bloc laparoscopic nephroureterectomy with bladder cuff resection is feasible and safe for upper tract transitional cell carcinoma.
Zou X, Zhang G, Wang X, Yuan Y, Xiao R, Wu G, Long D, Xu H, Wu Y, Liu F.
BJU Int. 2011 Nov;108(9):1497-500. doi: 10.1111/j.1464-410X.2010.10057.x. Epub 2011 Apr 11.
R11, a novel cell-permeable peptide, as an intravesical delivery vehicle.
Hsieh JT, Zhou J, Gore C, Zimmern P.
BJU Int. 2011 Nov;108(10):1666-71. doi: 10.1111/j.1464-410X.2011.10185.x. Epub 2011 Mar 31.
The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
Miyazaki J, Kawai K, Kojima T, Oikawa T, Joraku A, Shimazui T, Nakaya A, Yano I, Nakamura T, Harashima H, Akaza H.
BJU Int. 2011 Nov;108(9):1520-6. doi: 10.1111/j.1464-410X.2010.10056.x. Epub 2011 Feb 11.
Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.
van Rhijn BW.
BJU Int. 2011 Oct;108(7):1123-4. doi: 10.1111/j.1464-410X.2011.10344.x. Epub 2011 May 4. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on